Abstract:The field of autoimmune diseases in childhood presents challenges to physicians regarding diagnosis, monitoring, and treatment (1)(2)(3). Didactically, autoimmune diseases can be classified as organ-specific or multi-system organ involvement (1)(2)(3).Despite increasing research, the exact cause of autoimmune disorders is not entirely understood (1)(2)(3). The main feature of autoimmune diseases is immune dysregulation which leads to immune-mediated damage of healthy tissues and cells and results from the breakdown of the central or peripheral tolerance (1)(2)(3)(4). Autoimmune diseases in childhood are often less extensively studied (1)(2)(3). In this regard, understanding how autoimmune responses initiate and progress will allow the creation of novel therapeutics and improve the diagnoses and management strategies of these diseases (1)(2)(3).Autoimmune diseases in childhood, in particular, those of early onset (diagnosed at < 5 years of age), have been linked to a series of genetic determinants, including human leukocyte antigen (HLA) and non-HLA variants as well as gene variants related to inborn errors of immunity (5)(6)(7).Inborn errors of immunity (IEI) are genetic disorders that may manifest as increased susceptibility to infections, autoinflammatory, allergic, or malignant diseases, however, there are few IEI in which an autoimmune manifestation has never been observed (6). Regarding this, next-generation sequencing (NGS) has uncovered an array of genetic explanations for autoimmune diseases (6,8). Genetic variants can alter various cellular functions, and the relative risk of each in the disease phenotype's final effect can vary greatly (2,6). An example is the LRBA deficiency which may manifest as a common variable immune deficiency (CVID) as well as inflammatory bowel disease, endocrinopathies, autoimmune hemolytic anemia, thrombocytopenia, arthritis, and systemic lupus erythematosus (8). Another intriguing aspect of autoimmune diseases is that they can occur simultaneously (10). Thus, overt or latent polyautoimmunity is frequently observed in a single patient (10). Like this, Leong et al. reinforce that vitiligo may occur with various other autoimmune diseases such as psoriasis.Classically, autoantibodies are defined as biomarkers of autoimmune disease diagnosis, monitoring, and prediction (10,11). The array of available autoantibodies and Recently, the number of antibody-mediated disorders of the central nervous system

Die häufigsten Fiebersyndrome und autoinflammatorischen Erkrankungen im Erwachsenenalter

Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review

Fieber bei rheumatologischen Erkrankungen

Adult-onset systemic autoinflammatory disorders: a clinical approach

Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still’s Disease

Patient Experiences and Challenges in the Management of Autoinflammatory Diseases—Data from the International FMF & AID Global Association Survey

Vielfältige Entwicklungen aus Neurologie und Psychiatrie

Krankheitsbilder im Alter: Polymyalgia rheumatica, Riesenzellarteriitis, Schnitzler-Syndrom und VEXAS-Syndrom

Periphere neuroimmunologische Erkrankungen – neuropathologische Einsichten und klinische Perspektiven

Arthritis und Osteomyelitis im Kindes- und Jugendalter – bakteriell und nichtbakteriell

Unravelling the clinical heterogeneity of undefined recurrent fever over time in the European registries on Autoinflammation

Autoinflammatory Diseases: A Review

Autoantikörperdiagnostik bei idiopathisch inflammatorischen Myopathien

Autoinflammation: Past, Present, and Future

Psoriasis im Kindes- und Jugendalter

Idiopathische inflammatorische Myopathien

Identification by Exome Sequencing of Predisposing Variants in Familial Cases of Autoinflammatory Recurrent Fevers

Mikrobielle und genetische Faktoren in der Pathogenese der Spondyloarthritis

Auto-immuno-deficiency syndromes

Editorial: Autoimmune diseases in childhood

How autoinflammation may turn into autoimmune inflammation: Insights from monogenetic and complex IL-1 mediated auto-inflammatory diseases